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leak; (2) the differences in LOS, readmission, post-operative infection, and total
inpatient costs between the patients with anastomotic leaks and those without
leaks. Chi square test and T test were used to compare outcomes between two
cohorts, before and after employing propensity-score matching technique based
on a series of baseline covariates. Generalized linear model was also conducted.
RESULTS: A total of 6174 (6.18%) patients with colorectal surgeries had 30-day
anastomotic leak during 2008-2010.The patients with anastomotic leak had 1.3
times higher 30-day readmission (p0.01), and 1.9 times higher postoperative in-
fection (p0.01) compared to the patient without anastomotic leak. Anastomotic
leak incurred additional LOS of 7.3 days and additional average hospital cost of
$24,399 for index hospitalization alone. When the extra burden of readmission was
added, the average incremental LOS increased to 9.5 days, and the average incre-
mental hospital costs increased to $28,597. CONCLUSIONS: Anastomotic leaks in
colorectal surgeries increase clinical and economic burden by 0.5 to 1.8 times in
terms of additional readmission, postoperative infection, LOS, and hospital costs.
The results underscore the potential advantage of cost reduction by preventing the
anastomotic leaks after colorectal surgeries.
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OBJECTIVES: To encourage quality improvements and assess high expenditures
for patients with coronary artery bypass graft (CABG) surgery and hospital quality
in Turkey. METHODS: Using the Turkish National Health Insurance Database
(2009-2011), CABG surgery patients were identified using the appropriate Interna-
tional Classification of Diseases Tenth Revision Clinical Modification codes. High-
cost cardiac surgery patients had annual health care costs in the top 20% post-
surgery. The empirical Bayes approach was used to combine mortality rates with
hospital volume for quality index, weighing observed mortality according to esti-
mation reliability, with the remaining weight placed on hospital volume. The rela-
tionship between hospital quality and high-cost payments was assessed using
chi-square tests. RESULTS: Total annual health care payments for 20,126 identified
CABG patients were approximately a70 million. High-cost patients incurred 31% of
the total expenditures. Although disease severity did not differ for patients across
hospitals, those in the lowest quintile cared for 25% of high-costs surgery patients,
compared with only 18% in the highest quality hospitals (p0.0001). a4M in asso-
ciated cost savings was calculated for patients shifting from low- to high-quality
hospitals. CONCLUSIONS: Results imply that hospital quality improvements can
reduce costs and improve morbidity and mortality rates in Turkey.
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OBJECTIVES: Estimate the cost of a adhesiolysis (surgical procedure to remove
adhesions abdomen or pelvis) in the Brazilian private health care system.
METHODS: Using a claims database, 1585 patients were classified according to
code Brazilian Private HealthCare System (TUSS code) and observed between Jan-
uary/2009 to December/2011 all costs associated with the surgical procedure to
remove adhesions abdomen or pelvis were considered across seven major catego-
ries: materials, medications, procedure, exams, alimentation, rates and medicinal
gases. RESULTS: Out of the 1585 patients that used the private health care system
and made a adhesiolysis in a period of 36 months, 93% are women and the majority
between 30 -34 years old (27,22%) with an expenditure of about R$ 13millhon with
average cost , per patient of R$ 8.228,39 were hospitalized for 4 days. The 56% of
patients remove the adhesion after a surgical abdominal or pelvic and them ex-
penditure 51% was due to procedure and materials, followed by rates (21%), med-
ication (20%), alimentation (3%), exams (3%) and medicinal gases (2%).
CONCLUSIONS: . Procedure spending of adhesiolysis could have been avoided if
there was the use of barreir.
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OBJECTIVES: A recent pilot study suggests the current NHS HRG Tariff for parathy-
roidectomy (PTX) (£2,710 and £2,209 in patients with and without complications
respectively) is not representative of the true costs of surgery in patients with
secondary hyperparathyroidism (SHPT). This study aims to describe the health
care resources used to manage patients undergoing PTX, for SHPT, and estimate
the cost in a UK tertiary care centre. METHODS: Resource use was identified by
combining data from the PROTON renal database, and routine hospital data, for all
adults undergoing PTX for SHPT at Cardiff and Vale University Health Board from
2000-2008. Data were supplemented by a questionnaire completed by clinicians in
the Cardiff centre. Costs were obtained from the NHS reference costs, British Na-
tional Formulary and published literature. These costs were applied for the follow-
ing periods: pre-surgical, surgical, peri-surgical, and post-surgical to calculate the
total cost of PTX. RESULTS: The analysis included 124 patients (mean age 51.0, SD
13.8). Patients’ underlying renal disease had a wide range of causes, undergoing
renal replacement therapy for a mean of 7.3 years, SD 7.0 prior to PTX. The main
costs identified included the surgical stay (average £4,100, SD £2,338; mean stay 5.6
days, SD 7.4), yearly post-discharge outpatient surveillance (£735, £147 and £147, in
the first, second and third years respectively) and medications (£733, £650 and £643,
in the first, second and third years respectively). Average total cost for the pre-
surgical, surgical, and peri-surgical periods amounted to £4,968 (SD £2,361).
CONCLUSIONS: This analysis demonstrates that the cost of PTX surgery in SHPT
exceeds the current NHS HRG tariffs for PTX.
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DOES THE NOVEL RENAL MARKER NGAL (NEUTROPHIL GELATINASE-
ASSOCIATED LIPOCALIN) RESULT IN COST SAVINGS IN PATIENTS WITH RENAL
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OBJECTIVES: Cardiac surgery can result in renal impairment necessitating hemo-
filtration (HF; dialysis) which prolongs the length of therapy (LOT), days in the
intensive care unit (ICU) and is associated with an overall higher mortality. The
decision to initiate HF-therapy is currently made on increased plasma creatinine
levels, a relatively late marker (peaking days after a potentially reversible renal
dysfunction). The novel urine marker NGAL (neutrophil-gelatinase-associated li-
pocalin) measures the acute structural damage and identifies the need for HF
within hours with high accuracy. METHODS: Based on data collected in 2005-2009,
we prospectively included NGAL in an algorithm to modify the management of
HF-therapy in 2010. Changes in incidence of HF and LOT, all costs associated with
routine NGAL-testing and ICU stay (direct and indirect) as well as the economic
impact were analysed. RESULTS: A total of 528 patients were operated with no
statistical difference in numbers, case mix, risk scores and outcomes to the previ-
ous years. The expected number of patients with HF was 45.3 with an average LOT
of 7.7 days (2005-2009). Introduction of NGAL-testing added costs of € 60.00/patient
(€ 31.680/year). Although € 2047,50/day could be realized through public health
refunding, the fixed associated costs were € 3249,70/patient/day [€ 892,52 for all
supplies to operate the HF (Prismaflex, Gambro, Germany) and € 2357,18 for insti-
tutional ICU expenditure (incorporating personnel costs)] resulting in a deficit of €
1202,19/day with, and € 751,58 without HF operating. Using the new marker, only 32
patients required treatment with HF for a mean of 5.5 days and earlier initiation (1.1
days) in 2010 (p0,001). A total of 41.6 days of treatment in ICU (occupancy) were
avoided with savings of € 44.153,16. CONCLUSIONS: Routine NGAL testing and
consecutive changes in management reduced the number of HF-therapies, lengths
of therapy and ICU stay in our institution and proved to be cost-saving.
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OBJECTIVES: Minimally invasive surgery techniques (MIS) for lumbar spine fusion
allow surgical treatment of back and leg pain while aiming at minimizing tissue
injury and accelerating patient recovery. The objective of this study was to esti-
mate the cost-effectiveness of MIS compared to open surgery (OS) for the treatment
of degenerative lumbar spinal conditions in a UK setting. METHODS: Resources,
costs and differences in Health Related Quality of Life (HRQoL) after MIS and OS
were based on a literature review or derived from other public sources. Resources
included were: staff and operating room, surgical equipment, consumables, blood
loss, surgical drainage, duration of hospitalization and post-operative complica-
tions. In the base case it was assumed that the surgeons hadn’t reached the top of
the learning curve. The cost-effectiveness was expressed as the incremental cost
per QALY gained using a time horizon of two years after surgery. The costs included
the total direct medical cost associated with either procedure and the utility gain
was estimated from the Swedish national spinal registry data. RESULTS: Modeling
showed that MIS was the dominant strategy vs. open surgery yielding both cost
savings and improved HRQoL. Cost savings were driven mainly by shorter length of
hospital stay, less blood loss and fewer complications. The total cost-saving was
£639 per procedure with a small improvement in HRQoL (0.04 QALY gain after 2
years). CONCLUSIONS: MIS may be a dominant treatment option compared to OS
for spinal lumbar fusion in a UK setting. Lower costs and increased HRQoL in the
MIS group compensate for potential higher upfront costs of MIS implants and
equipment. Future analyses should consider the inclusion of indirect costs as the
majority of the patient population is below age 65 and will potentially return to
work.
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SENTINEL LYMPH NODE BIOPSY LESS EXPENSIVE THAN AXILLARY LYMPH
NODE DISSECTION IN EARLY BREAST CANCER STAGING
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OBJECTIVES: As part of the information needed for recommendations making, we
aimed to compare the cost of systematic axillary lymph node dissection and sen-
tinel lymph node biopsy –with axillary dissection only if the sentinel node contains
metastases-, with or without intra-operative histological examination. METHODS:
Unit costs collected in a French national study were included in a model simulating
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the cost of 3 strategies: 1) axillary lymph node dissection; 2) sentinel lymph node
biopsy followed by distant axillary lymph node dissection in case of positive sen-
tinel lymph node; and and 3) sentinel lymph node biopsy with intra-operative
histological examination and axillary lymph node dissection for positive cases. A
multivariate probabilistic sensitivity analysis was conducted on identification rate,
complication rates, sensitivity, specificity and length of hospital stay. RESULTS:
The sentinel mph node biopsy is less costly than lyaxillary lymph node dissection
in the early stages of breast cancer. Intra-operative histological examination of
sentinel lymph node significantly reduces the cost of the procedure. Data on mo-
lecular intra-operative examination couldn’t be integrated in the present study as
no French cost data were available. In a systematic review, no survival difference
could be demonstrated between the three strategies in early stage of breast cancer
and quality of life was found to be better with sentinel lymph node biopsy than
with axillary lymph node dissection. Nevertheless, more data are needed to inte-
grate these results in a cost-effectiveness analysis. CONCLUSIONS: The study con-
firms the interest of sentinel lymph node biopsy in early stage of breast cancer. The
cost comparison helps to determine the choice of the intervention alongside other
arguments as women’s preference, efficacy and safety.
SURGERY - Patient-Reported Outcomes & Patient Preference Studies
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OBJECTIVES: The advent of robotic surgery to prostate cancer treatment has been
justified by improved convalescence, fewer medical complications and decreased
morbidity in comparison with traditional operating techniques. Furthermore, ro-
botic surgery has been claimed to achieve better results concerning urinary conti-
nence and sexual factors. Our aim was to find out whether these claims are realized
in an unselected material of a large university hospital. METHODS: An ongoing
observational follow-up study in the real-world setting of a university hospital
using the 15D generic health-related quality of life (HRQoL) instrument. Patients
entering for treatment of prostate cancer were asked to fill in the HRQoL question-
naire at baseline and 3, 6, 12 and 24 months after entering treatment. RESULTS: So
far, 123 patients have undergone surgery: 76 in the robot-assisted laparoscopic
prostatectomy group (RALP, mean age 60.6 years) and 47 in the open surgery group
(OS, mean age 61.5 years). The baseline prognostic Gleason score did not differ in a
statistically significant manner between the groups (6.91 vs. 6.98, p0.593). The
mean HRQoL score in the OS group was slightly lower at baseline than that in the
RALP group (0.940 vs. 0.920), but the difference was not statistically significant.
During the two-year follow-up the HRQoL score remained slightly lower in the OS
group at all follow-up points, but none of the differences was statistically signifi-
cant. At the three-month follow-up the RALP group fared statistically significantly
better on the dimensions of “excretion” (p0.05) and “sexual activity” (p0.01), but
at the subsequent follow-up points the statistically significant difference had dis-
appeared. The dimension of “vitality” did not differ between the groups at any of
the follow-up points. CONCLUSIONS: The benefit from robot-assisted prostate sur-
gery was in our material so small that it probably does not offset the high cost
associated with the robotic approach.
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WOMEN’S PREFERENCES FOR BREAST RECONSTRUCTION: A STUDY USING A
DISCRETE CHOICE EXPERIMENTS
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OBJECTIVES: Immediate or early breast reconstruction (BR) a viable option for the
majority of women with breast cancer. However, only 5.6% of the mastectomy
patients underwent BR in Taiwan. Quantitative evidence on the preferences of
women for BR is limited; this study, therefore, elicits such preferences. METHODS:
Face to face patient interviews were conducted on 156 women who had previously
undergone a therapeutic mastectomy, of whom 60 had also undergone a BR. These
women were asked to choose between hypothetical BR profiles featuring six attri-
butes: (1) material used for reconstruction, (2) number and duration of operations,
(3) failure rate, (4) aesthetic result and (5) out-of-pocket payment (in NT$), and
additionally had the option to choose not to undergo BR. The relative importance of
attributes and trade-offs that the patients were willing to make among them were
examined using a conditional logit regression model. RESULTS: Coefficients for all
treatment attributes were significant with a prior expected direction. Women had
a significant positive preference for autologous tissues, shorter operations, ‘excel-
lent’ aesthetic results, a reduction in failure rate and in out-of-pocket payments.
Expected 1% reductions in the chance of failure were associated with a willingness
to pay of $NT40,000. Women would be willing to pay NT$22,000 to replace implants
with autologous tissues, NT$81,000 to reduce operation time from 8 hours to 2
hours, and NT$86,000 to increase the aesthetic result from ‘excellent’ to
‘moderate’. CONCLUSIONS: These findings provide insight into how BR are viewed
and valued by women, and how future advances in surgical techniques will in-
crease the uptake of BR by meeting women’s preferences for reduction in length of
time of operations and failure rate, as well as improvement in aesthetic results.
PSU24
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OBJECTIVES: The collection of pre- and post-operative Patient Reported Outcome
(PROs) have traditionally been used to assess the benefit of medical and surgical
interventions. More recently, individual patient level PROs have been used in ev-
eryday clinical practice. Online website ‘electronic’ collection, so called remote
ePROs, provides a platform to collect scores at regular intervals and report results
back to both patients and their clinicians. Chronic conditions can then be moni-
tored over time to compare the response to treatment with that of other patients.
The primary aim of this study was to assess whether scores collected electronically
via an online internet website (ePROs) are equivalent to scores collected via the
traditional pen and paper format (PROs). METHODS: A group of 47 patients, who
had previously undergone open hip debridement for femeroacetabular impinge-
ment, were allocated to one of two groups as part of a randomized crossover study.
As per the ‘International Society for Pharmacoeconomics and Outcomes Research
(ISPOR) ePRO Good Research Practices Task Force Report’, this study was powered
to rule out a difference between PRO and ePRO assessment of 0.3 standard devia-
tions. Group 1 completed the online ePRO scores- Oxford, McCarthy, UCLA and
HowRu score- followed by the PRO paper equivalents one week later, and Group 2
completed the scores in reverse order.RESULTS:The difference between the online
ePRO and paper PRO Oxford score in Group 1 was 1.6, 0.9 to 2.4 (mean, 95% confi-
dence interval (CI)) and in Group 2 was 0.8, 0.2 to 1.3 (mean, 95% CI). There was no
significant difference between Group 1 and Group 2. Therefore analysis revealed an
ePRO Oxford score of 32.8, 29.7 to 35.8 (mean, 95% CI) and a PRO score of 33.0, 29.9
to 36.1 (mean, 95% CI). CONCLUSIONS: Remote online ePRO score collection using
this website is equivalent to paper PRO collection.
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OBJECTIVES: Vertebral compression fractures (VCFs) are a fairly common and
painful result of cancer but little is known about the quality of life (QoL) in these
patients. The randomised controlled trial (RCT) CAFE, comparing balloon kyphop-
lasty (BKP) to non-surgical management (NSM), is the only RCT that has been
conducted in cancer patients with VCFs. The objective of this study was to use data
from CAFE to analyse QoL in cancer patients with VCFs and to analyse the impact
of BKP on QoL in these patients. METHODS: SF-36 data from the CAFE study were
analysed. Answers to the SF-36 questionnaire were translated into eight subcate-
gories which in turn were mapped to health utilities. At baseline, complete data
were available for 55 patients in the control group 65 patients in the treatment
group; both groups had lost seven at 1 month’s follow-up. Although the original
study ran for 12 months, high crossover rates from control group to treatment after
1 month posed a challenge to an analysis of long-term QoL effects. RESULTS: At
baseline, the NSM group had a mean utility (SE) of 0.27 (0.027) while the BKP group
had 0.30 (0.027). After 1 month, the NSM group had a utility of 0.30 (0.030) and the
BKP group 0.63 (0.029). The difference in utility at 1 month (0.33) was statistically
significant (p0.001). No significant differences in baseline QoL or QoL impact of
BKP were observed between different underlying cancer types. . Health utilities
appeared to be relatively stable between 1 month and 12 months. CONCLUSIONS:
VCFs in cancer patients are associated with significant QoL impairment. QoL is
meaningfully improved by treating painful VCFs with BKP, independently of the
underlying cancer type. This information can be used as a basis for further re-
search, such as analyses of the cost-effectiveness of BKP.
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OBJECTIVES: Liver transplantation (LTx) is indicated in familial amyloid polyneuropathy
(FAP) to prevent long term disease progression. This study aims to assess health-related
quality of life (HRQoL) in FAP patients before and after LTx. METHODS: A systematic
review was conducted by January 2012 through Cochrane Collaboration, Medline,
EMBASE, and Lilacs databases. Outcome measures were mental and physical di-
mensions assessed by HRQoL questionnaires. RESULTS: Five studies met eligibility
criteria. Before LTx, FAP patients presented lower scores measured by EuroQol
(EQ-5D) index when compared to general population (18-34 years: 0.810.02; 35-49
years: 0.680.03; 50-64 years: 0.570.04; 65 years: 0.580.05 versus 0.920.00;
0.880.00; 0.840,00, and 0.790,00, respectively; p0.0001 for all comparisons).
When compared to other chronic diseases, FAP presented a significantly worse
HRQoL (FAP[50-64 years]: 0.58; diabetes: 0.76; stroke: 0.69; emphysema: 0.68; heart
failure: 0.64; rheumatoid arthritis: 0.66; p 0.0001 for all comparisons). After LTx,
HRQoL assessed by Short Form Health Survey (SF-36) was lower in FAP when com-
pared to non-PAF transplanted patients (p0.04). Physical and emotional well-
being domains 4 years after transplantation were significantly lower compared to
non-FAP transplanted (physical:35%-75%; emotional: 24%-54% reduction) and gen-
eral population (physical:16%-55%, emotional: 10%-39% reduction). A new score
was developed to measure the difference between HRQoL at 6 months after and
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